Talis Biomedical (TLIS) Institutional Ownership

$9.14
+0.14 (+1.56%)
(As of 04/26/2024 ET)

Institutional Ownership Changes (13F Filings) for Talis Biomedical (NASDAQ:TLIS)

Current
Institutional Ownership
Percentage
43.77%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$348.83K
Number of
Institutional Sellers
(last 12 months)
0
Get TLIS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Talis Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TLIS Institutional Buying and Selling by Quarter

Talis Biomedical Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/30/2024 BML Capital Management LLC42,743$318K0.2%N/A2.349%
12/6/2023Citigroup Inc.5,267$30K0.0%N/A0.289%
5/17/2022Greenlight Capital Inc.2,235,783$3.15M0.2%+42.5%8.399%
5/9/2022Qube Research & Technologies Ltd47,467$67K0.0%-19.8%0.178%
2/14/2022Greenlight Capital Inc.1,569,300$6.29M0.4%N/A5.969%
2/10/2022Qube Research & Technologies Ltd59,161$237K0.0%+153.9%0.225%
2/4/2022Mercer Global Advisors Inc. ADV11,035$44K0.0%-44.9%0.042%
2/1/2022Qube Research & Technologies Ltd59,161$237K0.0%+153.9%0.225%
11/18/2021Personal CFO Solutions LLC17,000$106K0.0%N/A0.065%
11/17/2021ArrowMark Colorado Holdings LLC5,893,876$36.84M0.3%+0.4%22.420%
11/12/2021Geode Capital Management LLC302,968$1.89M0.0%+17.4%1.179%
11/9/2021BlackRock Inc.813,137$5.08M0.0%+0.7%3.165%
11/4/2021Deutsche Bank AG15,007$94K0.0%+85.9%0.058%
9/3/2021Parametric Portfolio Associates LLC50,496$557K0.0%+21.3%0.197%
8/25/2021Marshall Wace LLP11,326$125K0.0%-80.2%0.044%
8/17/2021ArrowMark Colorado Holdings LLC5,871,925$32.69M0.2%-2.2%22.856%
8/16/2021Cubist Systematic Strategies LLC22,920$253K0.0%N/A0.089%
8/16/2021Redmile Group LLC363,849$4.01M0.1%-9.0%1.416%
8/16/2021Alyeska Investment Group L.P.100,000$1.10M0.0%+100.0%0.389%
8/16/2021Morgan Stanley442,250$4.88M0.0%+2,458.6%1.721%
8/16/2021Charles Schwab Investment Management Inc.95,996$1.06M0.0%+2.5%0.374%
8/16/2021State Street Corp205,925$2.27M0.0%+40.0%0.802%
8/16/2021Nuveen Asset Management LLC40,060$442K0.0%+87.1%0.156%
8/16/2021Federated Hermes Inc.15,000$165K0.0%-98.5%0.058%
8/16/2021Marshall Wace LLP11,326$125K0.0%-80.2%0.044%
8/13/2021Geode Capital Management LLC258,043$2.85M0.0%+11.2%1.006%
8/13/2021Vanguard Group Inc.544,906$6.01M0.0%+39.7%2.125%
8/12/2021JPMorgan Chase & Co.42,230$466K0.0%-73.4%0.165%
8/11/2021Bank of New York Mellon Corp84,983$938K0.0%+6.3%0.331%
8/11/2021BlackRock Inc.807,299$8.90M0.0%+11.8%3.149%
8/10/2021Nicholas Investment Partners LP1,071,315$11.82M0.7%-2.7%4.179%
8/5/2021 Legato Capital Management LLC18,585$205K0.0%N/A0.072%
8/5/2021Capital Analysts LLC3,600$40K0.0%N/A0.014%
8/5/2021Rhumbline Advisers12,976$143K0.0%N/A0.051%
8/2/2021New York State Common Retirement Fund38,414$424K0.0%-2.9%0.150%
6/10/2021Perceptive Advisors LLC250,000$3.21M0.0%N/A0.975%
5/18/2021Baker BROS. Advisors LP7,574,835$97.34M0.4%N/A29.545%
5/18/2021Tudor Investment Corp Et Al10,000$129K0.0%N/A0.039%
5/18/2021Redmile Group LLC400,000$5.14M0.1%N/A1.560%
5/18/2021Alyeska Investment Group L.P.50,000$643K0.0%N/A0.195%
Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.
5/18/2021Boxer Capital LLC1,550,998$19.93M0.7%N/A6.050%
5/18/2021California State Teachers Retirement System19,965$257K0.0%N/A0.078%
5/17/2021Perceptive Advisors LLC250,000$3.21M0.0%N/A0.975%
5/17/2021Caas Capital Management LP40,000$514K0.0%N/A0.156%
5/17/2021Nuveen Asset Management LLC21,415$275K0.0%N/A0.084%
5/14/2021Laurion Capital Management LP10,000$129K0.0%N/A0.039%
5/14/2021Nicholas Investment Partners LP1,101,401$14.15M1.0%N/A4.296%
5/14/2021Sectoral Asset Management Inc405,094$5.21M0.4%N/A1.580%
5/13/2021Bank of New York Mellon Corp79,941$1.03M0.0%N/A0.312%
5/13/2021Federated Hermes Inc.1,030,000$13.24M0.0%N/A4.017%
5/12/2021Northern Trust Corp138,481$1.78M0.0%N/A0.540%
5/12/2021Geode Capital Management LLC232,026$2.98M0.0%N/A0.905%
5/12/2021JPMorgan Chase & Co.158,683$2.04M0.0%N/A0.619%
5/12/2021UBS Group AG3,211$41K0.0%N/A0.013%
5/11/2021Mercer Global Advisors Inc. ADV20,035$257K0.0%N/A0.078%
5/11/2021New York State Common Retirement Fund39,553$508K0.0%N/A0.154%
5/7/2021BlackRock Inc.722,407$9.28M0.0%N/A2.818%
5/7/2021American International Group Inc.7,715$99K0.0%N/A0.030%
5/6/2021M&T Bank Corp15,202$195K0.0%N/A0.059%
4/27/2021Janney Montgomery Scott LLC10,000$128K0.0%N/A0.039%
(Data available from 1/1/2016 forward)

TLIS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TLIS shares?

During the previous two years, the following institutional investors and hedge funds held shares of Talis Biomedical shares: Greenlight Capital Inc. ($3.15M), BML Capital Management LLC ($318K), and Qube Research & Technologies Ltd ($67K), Citigroup Inc. ($30K).Learn more on TLIS's institutional investors.

What percentage of Talis Biomedical stock is owned by institutional investors?

43.77% of Talis Biomedical stock is owned by institutional investors. Learn more on TLIS's institutional investor holdings.

Which institutional investors have been buying Talis Biomedical stock?

The following institutional investors have purchased Talis Biomedical stock in the last 24 months: Greenlight Capital Inc. ($666.48K), BML Capital Management LLC ($42.74K), and Citigroup Inc. ($5.27K).

How much institutional buying is happening at Talis Biomedical?

Institutional investors have bought a total of 714,493 shares in the last 24 months. This purchase volume represents approximately $14.44M in transactions.

Which Talis Biomedical major shareholders have been selling company stock?

The following institutional investors have sold Talis Biomedical stock in the last 24 months: Qube Research & Technologies Ltd ($11.69K).

How much institutional selling is happening at Talis Biomedical?

Institutional investors have sold a total of 11,694 shares in the last 24 months. This volume of shares sold represents approximately $247.33K in transactions.


This page (NASDAQ:TLIS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners